Using Western blotting, we further confirmed the increased levels of the 21 kDa cleaved product of LB1 in hippocampal samples from AD patients (n = control 7, AD 10, p < 0.05) (Figure 3c,d). This evidence concerns the gene CKAP2 and Alzheimer disease.